1. Home
  2. LNC vs BBIO Comparison

LNC vs BBIO Comparison

Compare LNC & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNC
  • BBIO
  • Stock Information
  • Founded
  • LNC 1905
  • BBIO 2015
  • Country
  • LNC United States
  • BBIO United States
  • Employees
  • LNC N/A
  • BBIO N/A
  • Industry
  • LNC Life Insurance
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNC Finance
  • BBIO Health Care
  • Exchange
  • LNC Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • LNC 8.0B
  • BBIO 9.4B
  • IPO Year
  • LNC N/A
  • BBIO 2019
  • Fundamental
  • Price
  • LNC $42.89
  • BBIO $51.22
  • Analyst Decision
  • LNC Hold
  • BBIO Strong Buy
  • Analyst Count
  • LNC 9
  • BBIO 16
  • Target Price
  • LNC $39.56
  • BBIO $62.56
  • AVG Volume (30 Days)
  • LNC 1.7M
  • BBIO 3.0M
  • Earning Date
  • LNC 07-31-2025
  • BBIO 08-05-2025
  • Dividend Yield
  • LNC 4.19%
  • BBIO N/A
  • EPS Growth
  • LNC N/A
  • BBIO N/A
  • EPS
  • LNC 6.00
  • BBIO N/A
  • Revenue
  • LNC $18,036,000,000.00
  • BBIO $235,812,000.00
  • Revenue This Year
  • LNC $7.16
  • BBIO $115.49
  • Revenue Next Year
  • LNC $4.00
  • BBIO $64.61
  • P/E Ratio
  • LNC $7.15
  • BBIO N/A
  • Revenue Growth
  • LNC 31.97
  • BBIO 7.62
  • 52 Week Low
  • LNC $27.58
  • BBIO $21.72
  • 52 Week High
  • LNC $43.12
  • BBIO $52.85
  • Technical
  • Relative Strength Index (RSI)
  • LNC 73.65
  • BBIO 65.14
  • Support Level
  • LNC $41.70
  • BBIO $46.81
  • Resistance Level
  • LNC $42.92
  • BBIO $50.73
  • Average True Range (ATR)
  • LNC 0.76
  • BBIO 1.75
  • MACD
  • LNC 0.10
  • BBIO 0.16
  • Stochastic Oscillator
  • LNC 99.67
  • BBIO 99.59

About LNC Lincoln National Corporation

Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: